Dopamine receptors, nicotinic acetylcholine receptors, and opioid receptors (DR, nAChR, OR)

Dopamine receptors, nicotinic acetylcholine receptors (nAChRs), and opioid receptors represent three distinct but functionally interrelated classes of neuroreceptors. Dopamine receptors are G protein-coupled receptors (GPCRs) that mediate the effects of the neurotransmitter dopamine, playing critical roles in motor control, motivation, and the brain's reward system [1, 2]. Nicotinic acetylcholine receptors are ligand-gated ion channels that facilitate rapid synaptic transmission and modulate the release of various neurotransmitters, including dopamine, thereby influencing cognitive and addictive processes [3, 4]. Opioid receptors are GPCRs that respond to endogenous and exogenous opioids to regulate pain, stress, and emotional homeostasis [5, 6]. These three systems are central to the mesolimbic pathway, where their convergence is a primary driver of substance use disorders and reinforcement behaviors [1, 5]. Pharmacological agents targeting these receptors are widely used to treat conditions such as Parkinson's disease, schizophrenia, chronic pain, and nicotine addiction [2, 4, 6]. Because this entry combines three separate receptor families, it is categorized as a composite target rather than a single molecular entity.

Other names

Dopaminergic receptorsNicotinic receptorsOpiate receptorsReward system receptors

Modulation of intracellular signaling pathways (via G proteins) and membrane potential (via ion flux) to regulate neuronal excitability and synaptic plasticity [1, 3, 5].